Metalyse 10'000 U, Injektionspräparat

7680554180057 CH-55418 Injektionspräparat
Metalyse 10'000 U, Injektionspräparat
Metalyse 10'000 U, Injektionspräparat
Metalyse 10'000 U, Injektionspräparat
1 / 3
google

Article details

Package size
1 + 1
Selling units
1
Measure
Stück
Galenic form
Injektionspräparat
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
14/03/2025
Summary of Product Characteristics
Français
14/03/2025
Summary of Product Characteristics
Italien
14/03/2025

Detailed composition

Substance Quantity Type Category
SOLV
10.0 ML Substance HNIDK
PRC
50.0 MG Substance Wirkstoff (Principe actif)
PRC
- Substance HNIDK
SOLV
5.0 MGML Substance Wirkstoff (Principe actif)
PRC
- Substance HNIDK
acidum phosphoricum concentratum
- Substance HNIDK

Authorization holder

Boehringer Ingelheim (Schweiz) GmbH

4057 Basel

Authorization information

Swissmedic authorization number
55418
Drug name
Metalyse, Injektionspräparat
Galenic form
PULP
ATC Code
B01AD11
Authorization status
Z
Dispensing category
B
First authorization
29/06/2000
Authorization expiration date
31/12/9999
IT Number
06.05.0.
Domain
Human medicine
Field of application
Thrombolytische Therapie bei akutem Herzinfarkt

Package details

Description (FR)
METALYSE 10000 U c solv (ser prê 10ml) flac
Description (DE)
METALYSE 10000 E c Solv (Fertspr 10ml) Durchstf
Market launch
29/06/2000
Narcotic (BTM)
No

Other package sizes (2)

None
1 + 1 STU
GTIN: None
Not in V1
METALYSE 8000 U c solv (ser prê 8ml) flac
1 + 1 STU
GTIN: 7680554180033
Not in V1